Hiscox Ltd Share Price London S.E.
Equities
HSX
BMG4593F1124
Property & Casualty Insurance
End-of-day quote
Other stock markets
|
||
- GBP | - |
08/05 | UBS raises Centrica to 'buy' from 'neutral | AN |
07/05 | AstraZeneca target raised; Antofagasta lowered | AN |
Sales 2024 * | 3.89B 4.96B 412B | Sales 2025 * | 4.27B 5.44B 452B | Capitalization | 4B 5.1B 424B |
---|---|---|---|---|---|
Net income 2024 * | 469M 598M 49.69B | Net income 2025 * | 504M 643M 53.4B | EV / Sales 2024 * | 1.03 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 0.94 x |
P/E ratio 2024 * |
8.59
x | P/E ratio 2025 * |
7.88
x | Employees | - |
Yield 2024 * |
2.77% | Yield 2025 * |
3.07% | Free-Float | 97.45% |
Latest transcript on Hiscox Ltd
Managers | Title | Age | Since |
---|---|---|---|
Hamayou Hussain
CEO | Chief Executive Officer | 51 | 22/16/22 |
Paul Cooper
DFI | Director of Finance/CFO | 52 | 12/22/12 |
Stéphane Flaquet
COO | Chief Operating Officer | - | 01/10/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 60 | 16/17/16 | |
Anne MacDonald
BRD | Director/Board Member | 68 | 20/15/20 |
Colin Keogh
BRD | Director/Board Member | 69 | 19/15/19 |
1st Jan change | Capi. | |
---|---|---|
+51.57% | 64.47B | |
+15.17% | 51.79B | |
+11.99% | 48.85B | |
+39.17% | 38.65B | |
+78.62% | 32.31B | |
+12.33% | 29.89B | |
+27.94% | 25.81B | |
+3.08% | 22.14B | |
+13.97% | 21.04B |
- Stock Market
- Equities
- HSX Stock
- HSX Stock